ABBVIE INC. vs. Maravai LifeSciences Holdings, Inc. Class A Common Stock
ABBV
ABBVIE INC.
$246.04 +0.89%
VS MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock
$6.23 -0.32%
ABBVIE INC. and Maravai LifeSciences Holdings, Inc. Class A Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | MRVI | |
|---|---|---|
| Market Cap | $434.78 billion | $918.96 million |
| Revenue (TTM) | $64.39 billion | — |
| Net Income (TTM) | $6.32 billion | — |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | MRVI | |
|---|---|---|
| P/E Ratio | 69.50 | — |
| Price / Book | -73.84 | — |
| Price / Sales | 6.75 | — |
ABBV and MRVI split the valuation factors evenly.
Profitability
| ABBV | MRVI | |
|---|---|---|
| Net Margin | 9.81% | — |
| Return on Equity | -107.29% | — |
ABBV and MRVI split the profitability factors evenly.
Dividend
| ABBV | MRVI | |
|---|---|---|
| Dividend Yield | 2.81% | — |
| Payout Ratio | 195.48 | — |
ABBV and MRVI split the dividend factors evenly.
Risk & Sentiment
| ABBV | MRVI | |
|---|---|---|
| Short Interest | 0.85% | 0.43% |
MRVI leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MRVI overview, MRVI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.